Click here to read the full article.
Top U.S. Food and Drug Administration (FDA) officials were excited by the response to the agency’s controversial ivermectin Twitter post, internal emails show.
The Aug. 21, 2021, post is now at the center of a court case.
Continue reading here.
Scroll down for comments and share your thoughts!